These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 24029957)
1. The use of connexin-based therapeutic approaches to target inflammatory diseases. O'Carroll SJ; Becker DL; Davidson JO; Gunn AJ; Nicholson LF; Green CR Methods Mol Biol; 2013; 1037():519-46. PubMed ID: 24029957 [TBL] [Abstract][Full Text] [Related]
2. Improved corneal wound healing through modulation of gap junction communication using connexin43-specific antisense oligodeoxynucleotides. Grupcheva CN; Laux WT; Rupenthal ID; McGhee J; McGhee CN; Green CR Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1130-8. PubMed ID: 22247467 [TBL] [Abstract][Full Text] [Related]
3. Acute downregulation of connexin43 at wound sites leads to a reduced inflammatory response, enhanced keratinocyte proliferation and wound fibroblast migration. Mori R; Power KT; Wang CM; Martin P; Becker DL J Cell Sci; 2006 Dec; 119(Pt 24):5193-203. PubMed ID: 17158921 [TBL] [Abstract][Full Text] [Related]
4. Connexin43 plays diverse roles in co-ordinating cell migration and wound closure events. Lorraine C; Wright CS; Martin PE Biochem Soc Trans; 2015 Jun; 43(3):482-8. PubMed ID: 26009195 [TBL] [Abstract][Full Text] [Related]
5. Connexin43 knockdown accelerates wound healing but inhibits mesenchymal transition after corneal endothelial injury in vivo. Nakano Y; Oyamada M; Dai P; Nakagami T; Kinoshita S; Takamatsu T Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):93-104. PubMed ID: 18172080 [TBL] [Abstract][Full Text] [Related]
6. Limiting burn extension by transient inhibition of Connexin43 expression at the site of injury. Coutinho P; Qiu C; Frank S; Wang CM; Brown T; Green CR; Becker DL Br J Plast Surg; 2005 Jul; 58(5):658-67. PubMed ID: 15927148 [TBL] [Abstract][Full Text] [Related]
7. The Connexin Mimetic Peptide Gap27 and Cx43-Knockdown Reveal Differential Roles for Connexin43 in Wound Closure Events in Skin Model Systems. Faniku C; O'Shaughnessy E; Lorraine C; Johnstone SR; Graham A; Greenhough S; Martin PEM Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463027 [TBL] [Abstract][Full Text] [Related]
8. Connexin43 and astrocytic gap junctions in the rat spinal cord after acute compression injury. Theriault E; Frankenstein UN; Hertzberg EL; Nagy JI J Comp Neurol; 1997 Jun; 382(2):199-214. PubMed ID: 9183689 [TBL] [Abstract][Full Text] [Related]
9. Connexin43 antisense oligodeoxynucleotide treatment down-regulates the inflammatory response in an in vitro interphase organotypic culture model of optic nerve ischaemia. Danesh-Meyer HV; Huang R; Nicholson LF; Green CR J Clin Neurosci; 2008 Nov; 15(11):1253-63. PubMed ID: 18824359 [TBL] [Abstract][Full Text] [Related]
10. Abnormal connexin expression underlies delayed wound healing in diabetic skin. Wang CM; Lincoln J; Cook JE; Becker DL Diabetes; 2007 Nov; 56(11):2809-17. PubMed ID: 17717278 [TBL] [Abstract][Full Text] [Related]
11. Blocking connexin43 expression reduces inflammation and improves functional recovery after spinal cord injury. Cronin M; Anderson PN; Cook JE; Green CR; Becker DL Mol Cell Neurosci; 2008 Oct; 39(2):152-60. PubMed ID: 18617007 [TBL] [Abstract][Full Text] [Related]
12. The connexin mimetic peptide Gap27 increases human dermal fibroblast migration in hyperglycemic and hyperinsulinemic conditions in vitro. Wright CS; Pollok S; Flint DJ; Brandner JM; Martin PE J Cell Physiol; 2012 Jan; 227(1):77-87. PubMed ID: 21984074 [TBL] [Abstract][Full Text] [Related]
13. Connexins, a new target in wound treatment. Chin KY J Wound Care; 2011 Aug; 20(8):386-90. PubMed ID: 21841715 [TBL] [Abstract][Full Text] [Related]
14. Expression and function of connexins in the epidermis, analyzed with transgenic mouse mutants. Kretz M; Maass K; Willecke K Eur J Cell Biol; 2004 Dec; 83(11-12):647-54. PubMed ID: 15679109 [TBL] [Abstract][Full Text] [Related]
15. Gap junction remodeling in skin repair following wounding and disease. Churko JM; Laird DW Physiology (Bethesda); 2013 May; 28(3):190-8. PubMed ID: 23636264 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic Targeting of Connexin Channels: New Views and Challenges. Delvaeye T; Vandenabeele P; Bultynck G; Leybaert L; Krysko DV Trends Mol Med; 2018 Dec; 24(12):1036-1053. PubMed ID: 30424929 [TBL] [Abstract][Full Text] [Related]
17. A model for ex vivo spinal cord segment culture--a tool for analysis of injury repair strategies. Zhang J; O'Carroll SJ; Wu A; Nicholson LF; Green CR J Neurosci Methods; 2010 Sep; 192(1):49-57. PubMed ID: 20654650 [TBL] [Abstract][Full Text] [Related]
18. Role of connexin43 in central nervous system injury. Chew SS; Johnson CS; Green CR; Danesh-Meyer HV Exp Neurol; 2010 Oct; 225(2):250-61. PubMed ID: 20655909 [TBL] [Abstract][Full Text] [Related]
19. Temporal regulation of connexin phosphorylation in embryonic and adult tissues. King TJ; Lampe PD Biochim Biophys Acta; 2005 Dec; 1719(1-2):24-35. PubMed ID: 16137642 [TBL] [Abstract][Full Text] [Related]
20. Connexin 43 mimetic peptides reduce swelling, astrogliosis, and neuronal cell death after spinal cord injury. O'Carroll SJ; Alkadhi M; Nicholson LF; Green CR Cell Commun Adhes; 2008 May; 15(1):27-42. PubMed ID: 18649176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]